Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Cost of Revenue (2022 - 2023)

Historic Cost of Revenue for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $80027.0.

  • Mainz Biomed's Cost of Revenue fell 4902.25% to $80027.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $385820.0, marking a year-over-year increase of 1095.52%. This contributed to the annual value of $319108.0 for FY2024, which is 1729.1% down from last year.
  • Latest data reveals that Mainz Biomed reported Cost of Revenue of $80027.0 as of Q4 2023, which was down 4902.25% from $94483.0 recorded in Q3 2023.
  • Mainz Biomed's Cost of Revenue's 5-year high stood at $156985.0 during Q4 2022, with a 5-year trough of $54136.0 in Q1 2022.